ALS News Today Forums › Forums › ALS Progress › Research Topics › Investigational ALS Therapy NPT520-34 Wins FDA Orphan Drug Status

  • Research Topics

    Investigational ALS Therapy NPT520-34 Wins FDA Orphan Drug Status

    Posted by als-news-today-moderator on September 3, 2019 at 10:39 am

    The FDA has granted orphan drug status to Neuropore’s investigational therapy NPT520-34 for the treatment of amyotrophic lateral sclerosis (ALS).  Read more about it here.

    What do you think of this news?

    replied 4 years, 7 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .